• Media type: E-Article
  • Title: Is the medical treatment for arterial hypertension after primary aortic coarctation repair related to age at surgery? A retrospective cohort study
  • Contributor: Lillitos, Peter J; Nassar, Mohamed S.; Tibby, Shane M; Simmonds, Joy; Salih, Caner; Austin, Conal; Anderson, David; Krasemann, Thomas
  • imprint: Cambridge University Press (CUP), 2017
  • Published in: Cardiology in the Young
  • Language: English
  • DOI: 10.1017/s1047951117001019
  • ISSN: 1467-1107; 1047-9511
  • Keywords: Cardiology and Cardiovascular Medicine ; General Medicine ; Pediatrics, Perinatology and Child Health
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:sec id="S1047951117001019_abs1" sec-type="general"><jats:title>Background</jats:title><jats:p>Hypertension following primary coarctation repair affects up to a third of subjects. A number of studies suggest that future hypertension risk is reduced if primary repair is performed at a younger age.</jats:p></jats:sec><jats:sec id="S1047951117001019_abs2" sec-type="objectives"><jats:title>Objectives</jats:title><jats:p>The objective of this study was to evaluate the risk of future medical treatment for hypertension depending on age of primary coarctation repair.</jats:p></jats:sec><jats:sec id="S1047951117001019_abs3" sec-type="methods"><jats:title>Methods</jats:title><jats:p>This study was carried out at a tertiary paediatric cardiology referral centre. Retrospective database evaluation of children aged &lt;16 years undergoing primary surgical coarctation repair between October, 2005 and October, 2014 was carried out. Patients with complex heart diseases were excluded. The following age groups were considered: neonate (⩽28 days), infant (&gt;28 days and ⩽12 months), and children (&gt;12 months). Main outcome measure is the need for long-term anti-hypertensive medication. The risk for re-coarctation was also evaluated.</jats:p></jats:sec><jats:sec id="S1047951117001019_abs4" sec-type="results"><jats:title>Results</jats:title><jats:p>A total of 87 patients were analysed: 60 neonates, 17 infants, 10 children. Among them, 6.7% neonates, 29.4% infants, and 40% children required long-term anti-hypertensive medications. Group differences were statistically significant (p=0.004). After adjustment for type of repair, the risk of long-term anti-hypertensive therapy was 4.5 (95% confidence interval 1.2–16.9, p=0.025) and 10.5 times (95% confidence interval 2.6–42.3, p=0.001) higher if primary repair was carried out in infancy and childhood, respectively, compared with neonates. Among all, 13 patients developed re-coarctation: 21.7% in the neonatal group, 5.9% in the infant group, and 20% in the child group. We could not demonstrate a significant difference between these proportions or calculate a reliable risk for developing re-coarctation.</jats:p></jats:sec><jats:sec id="S1047951117001019_abs5" sec-type="conclusions"><jats:title>Conclusions</jats:title><jats:p>Risk of medical treatment for hypertension was lowest when primary repair was carried out during the neonatal period, rising 10-fold if first operated on as a child. Knowing the likelihood of hypertension development depending on age of primary repair is useful for long-term surveillance and counselling.</jats:p></jats:sec>